Skip to content
Screener

Harrow HROW Other Income (Expense)

Other Income (Expense) at other companies

Bausch + Lomb logo
Bausch + LombBLCO
-$5M-150%
Ocular Therapeutix logo
Ocular TherapeutixOCUL
$4.73M+3,576%
Opko Health logo
Opko HealthOPK
-$6.43M+93.7%
Bausch Health Companies logo
Bausch Health CompaniesBHC
-$11M-175%
Tarsus Pharmaceuticals, Inc. logo
Tarsus Pharmaceuticals, Inc.TARS
$4.07M+121%
Schering-Plough logo
Schering-PloughSGP
$1.59M+214%

Other financials

Income statement

See full
Revenue$70.7M+10.9%
Gross profit$50.4M+6.0%
Operating income-$11.0M-196%
Net income-$17.3M-446%
EPS (diluted)-$0.46-454%

Balance sheet

See full
Cash & equivalents$83.9M+58.4%
Total debt$308.4M-32.0%
Total equity$15.2M-69.4%
Total assets$416.8M+20.8%

Cash flow

See full
Operating cash flow-$9.8M
CapEx$491.0K+196%
Free cash flow-$10.2M

Valuation

See full
Market cap$1.52B+22.5%
Enterprise value$1.74B+6.3%
P/S5.5×+0.1×

Profitability

See full
Gross margin73.3%-1.3pp
Operating margin-1%-7.3pp
Net margin-19.8%+18.0pp
FCF margin1.8%+1.3pp

Returns & leverage

See full
Return on equity-50%+17.5pp
Debt / equity20.3×+11.2×
Current ratio2.2×+1.6×

Where this comes from

Reported directly by Harrow in its filing.

Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.

The source filing: Harrow’s 10-Q, filed August 10, 2026.

Filed
Aug 10, 2026, 4:28 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-055271
Line itemFor the Three Months Ended June 30, 2026For the Three Months Ended June 30, 2025For the Six Months Ended June 30, 2026For the Six Months Ended June 30, 2025
Total operating expenses61,370,00036,103,000110,495,00079,642,000
(Loss) income from operations(11,007,000)11,409,000(33,087,000)177,000
Interest expense, net(6,263,000)(6,408,000)(11,760,000)(12,956,000)
Other (expense) income, net(6,000)(6,000)
(Loss) income before income taxes(17,270,000)4,995,000(44,847,000)(12,785,000)
Income tax expense(25,000)
Net (loss) income$(17,270,000)$4,995,000$(44,872,000)$(12,785,000)
Basic net (loss) income per share of common stock$(0.46)$0.14$(1.20)$(0.35)

Item 1. Financial Statements

FAQ

What is Harrow's other income (expense)?
Harrow (HROW) reported other income (expense) of $0 in Q2 2026.
How has Harrow's other income (expense) changed year-over-year?
Harrow's other income (expense) increased by 100.0% year-over-year, from -$6.41M to $0.
What is the long-term trend for Harrow's other income (expense)?
Over 3 years (2021 to 2025), Harrow's other income (expense) has grown at a 17.8% compound annual growth rate (CAGR), from -$19.49M to -$31.88M.
What does other income (expense) mean?
Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.

Ask your AI about Harrow's other income (expense).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude